Keck School Faculty

Alex Arto Balekian, MD
Alex Arto Balekian, MD
Assistant Professor of Clinical Medicine
Medicine
IRD 720 2020 Zonal Avenue Off Campus Los Angeles
Dr. Balekian's clinical interests include interstitial lung disease, pulmonary fibrosis, and critical care outcomes. His research interests include quality of care in lung cancer and racial and gender disparities in lung cancer.

Dr. Balekian earned his medical degree from University of California, San Diego. He then went on to complete his Masters in Health Services from UCLA School of Public Health. Dr. Balekian most recently completed his fellowship in Pulmonary/Critical Care from the UCLA David Geffen School of Medicine.

University of Texas, Southwestern: John S. Miller Award, Outstanding Senior Resident, 2006

University of Texas, Southwestern: Outstanding Teacher, 2004

University of California, Los Angeles: Regents Scholar, 1999

University of California, Los Angeles: Alumni Scholar, 1999

Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural EffusionsA Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2019 Jan; 16(1):124-131. . View in PubMed

Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial Chest. 2019 Jan; 155(1):44-52. . View in PubMed

Summary for Clinicians: Clinical Practice Guideline for Management of Malignant Pleural Effusions Ann Am Thorac Soc. 2018 Dec 05. . View in PubMed

Management of Malignant Pleural EffusionsAn Official ATS/STS/STR Clinical Practice Guideline. Am J Respir Crit Care Med. 2018 Oct 01; 198(7):839-849. . View in PubMed

Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions: A Systematic Review and Meta-Analysis Ann Am Thorac Soc. 2018 Oct 01. . View in PubMed

Surgical Disparities among Patients with Stage I Lung Cancer in the National Lung Screening Trial Chest. 2018 Jul 26. . View in PubMed

Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial Ann Am Thorac Soc. 2016 Sep; 13(9):1568-74. . View in PubMed

Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign Chest. 2016 Apr; 149(4):943-50. . View in PubMed

Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial Ann Am Thorac Soc. 2016 09; 13(9):1568-74. . View in PubMed

Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant Ann Am Thorac Soc. 2013 Dec; 10(6):629-35. . View in PubMed

Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest. 2013 May; 143(5 Suppl):e314S-e340S. . View in PubMed

Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest. 2013 May; 143(5 Suppl):e278S-e313S. . View in PubMed

Predicting in-hospital mortality among critically ill patients with end-stage liver diseaseJ Crit Care. 2012 Dec; 27(6):740. e1-7. . View in PubMed

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest. 2012 Feb; 141(2 Suppl):e195S-e226S. . View in PubMed

Powered by SC CTSI
Go to Top